Hepatitis B virus DNA and RNA persist in liver after serologic recovery in persons with hepatitis C virus.

HBV reactivation HBV recovery HBsAg source HCV-HBV co-infection cccDNA ddPCR integrated HBV DNA

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
23 May 2024
Historique:
received: 05 03 2024
revised: 27 04 2024
accepted: 06 05 2024
medline: 23 5 2024
pubmed: 23 5 2024
entrez: 23 5 2024
Statut: aheadofprint

Résumé

After recovery from a hepatitis B virus (HBV) infection, reactivation can occur with immunosuppression; thus, it is assumed that replication competent HBV persists in the liver. We sought to detect persistent HBV from 13 people with spontaneous recovery. We quantified HBV DNA and RNA in core liver biopsies (median 1.72x106 cells) from people who inject drugs (PWID). Among 13 biopsies, 8 (61%) had evidence of HBV DNA or RNA and 5 (38%) had both HBV DNA and RNA. mRNAs derived from cccDNA and integrated HBV DNA. Here, we show prevalent HBV DNA and RNA despite clinical recovery in PWID. We used a sensitive method to determine the amount of hepatitis B virus DNA or RNA in the livers of 13 individuals who recovered from hepatitis B virus infection. We found viral DNA or RNA in the liver in 61% of individuals despite no detectable virus in blood. Our findings support that eliminating all hepatitis B from the liver is a difficult treatment goal.

Autres résumés

Type: plain-language-summary (eng)
We used a sensitive method to determine the amount of hepatitis B virus DNA or RNA in the livers of 13 individuals who recovered from hepatitis B virus infection. We found viral DNA or RNA in the liver in 61% of individuals despite no detectable virus in blood. Our findings support that eliminating all hepatitis B from the liver is a difficult treatment goal.

Identifiants

pubmed: 38779916
pii: 7680230
doi: 10.1093/infdis/jiae248
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Tanner Grudda (T)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

David L Thomas (DL)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Gregory D Kirk (GD)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Shruti H Mehta (SH)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Jacquie Astemborski (J)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Georg M Lauer (GM)

Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA.
Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.

Ashwin Balagopal (A)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Chloe L Thio (CL)

Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

Classifications MeSH